Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Virion nucleic acid of Ebola virus.J Virol. 1980; 36: 465-469
- The origin and evolution of Ebola and Marburg viruses.Mol Biol Evol. 1997; 14: 800-806
- Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda.PLoS Pathog. 2008; 4: e1000212
- Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation.J Infect Dis. 1999; 179: S48-S53
- Ebola Reston in pigs and humans in the Philippines: update.(Available at:) (Accessed April 27, 2009)
- Marburg hemorrhagic fever, imported case—United States.(Available at:) (Accessed June 20, 2009)
- Epidemic and pandemic alert and response (EPR): case of Marburg haemorrhagic fever imported into the Netherlands from Uganda.(Available at:) (Accessed June 20, 2009)
- Biosafety in microbiological and biomedical laboratories.5th edition. U.S. Government Printing Office, Washington, DC2007
- Filoviridae: Marburg and Ebola viruses.in: Knipe B.M. Howley P.M. Griffen D.E. Fields virology. 5th edition. Lippincott-Raven, Philadelphia2007: 1409-1448
- Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.J Infect Dis. 2007; 196: S148-S153
- Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.J Infect Dis. 1999; 179: S177-S187
- Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome.J Virol. 2004; 78: 4330-4341
- Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.J Infect Dis. 1999; 179: S1-S7
- Pathologic features of filovirus infections in humans.Curr Top Microbiol Immunol. 1999; 235: 97-116
- Marburg-virus disease in Kenya.Lancet. 1982; 1: 816-820
- A case of Ebola virus infection.Br Med J. 1977; 2: 541-544
- Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit.J Infect Dis. 1999; 179: S28-S35
- Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.Int J Biochem Cell Biol. 2005; 37: 1560-1566
- Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.Am J Pathol. 2003; 163: 2347-2370
- Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.J Infect Dis. 2003; 188: 1618-1629
- DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells.Virology. 2003; 305: 115-123
- Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.Nat Med. 1999; 5: 423-426
- Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.Virology. 2001; 284: 20-25
- Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.J Infect Dis. 2003; 188: 1630-1638
- Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.J Immunol. 2003; 170: 2797-2801
- Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses.Lab Invest. 2000; 80: 171-186
- Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.J Virol. 1999; 73: 3491-3496
- Inhibition of IRF-3 activation by VP35 is critical for the high virulence of Ebola virus.J Virol. 2008; 82: 2699-2704
- A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.Virology. 2004; 328: 177-184
- Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.J Virol. 2006; 80: 5156-5167
- Emerging roles of tissue factor in viral hemorrhagic fever.Trends Immunol. 2004; 25: 461-464
- Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola.J Virol. 2006; 80: 6497-6516
- High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings.J Infect Dis. 2007; 196: S205-S212
- Interim guidance for managing patients with suspected viral hemorrhagic fever in U.S. Hospitals.(Available at:) (Accessed June 5, 2009)
- Assessment of the risk of Ebola virus transmission from bodily fluids and fomites.J Infect Dis. 2007; 196: S142-S147
- Patients infected with high-hazard viruses: scientific basis for infection control.Arch Virol Suppl. 1996; 11: 141-168
- Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda.Emerg Infect Dis. 2003; 9: 1430-1437
- Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread.Bull World Health Organ. 1983; 61: 997-1003
- Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995.J Infect Dis. 1999; 179: S263-S267
- Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.J Infect Dis. 1999; 179: S65-S75
- Marburg hemmorrhagic fever in Angola-Update 26.(Available at:) (Accessed June 7, 2009)
- Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.Antiviral Res. 2008; 78: 150-161
- Protective efficacy of neutralizing antibodies against Ebola virus infection.Vaccine. 2007; 25: 993-999
- Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.J Infect Dis. 1999; 179: S18-S23
- Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses.Arch Virol Suppl. 1996; 11: 135-140
- Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.J Infect Dis. 2007; 196: S400-S403
- Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.PLoS Pathog. 2007; 3: e9
- Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.Rev Infect Dis. 1989; 11: S750-S761
- Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.J Infect Dis. 1999; 179: S224-S234
- Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference.J Infect Dis. 2006; 193: 1650-1657
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.Lancet. 2003; 362: 1953-1958
- 3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice.Antiviral Res. 2002; 55: 151-159
- Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.Antiviral Res. 2000; 45: 135-147
- Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.J Infect Dis. 2007; 196: S390-S399
- Effective post-exposure treatment of Ebola infection.PLoS Pathog. 2007; 3: e2
- Status and challenges of filovirus vaccines.Vaccine. 2007; 25: 1923-1934
- Evaluation in nonhuman primates of vaccines against Ebola virus.Emerg Infect Dis. 2002; 8: 503-507
- Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys.J Biotechnol. 1996; 44: 111-118
- Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.FEMS Immunol Med Microbiol. 2004; 40: 27-31
- Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.J Infect Dis. 2007; 196: S430-S437
- Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.Vaccine. 2005; 23: 3033-3042
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.Expert Rev Vaccines. 2008; 7: 417-429
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
